Funding Rounds
AMLo Biosciences

AMLo Biosciences Unknown (2022, $3M)

AMLo Biosciences

Platform identifying high-risk melanoma through loss of specific skin proteins.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Unknown

Raised Amount: $3.20M

Raised Date: 2022-01-01

Investors